Articles

With Rocket Pharmaceuticals reaching a Phase II agreement with the FDA, RCKT stock soared, though some concerns linger. More

The companies below offer fair valuations, possible future growth, and little fluctuations in their underlaying share prices. More

These are the undervalued under $20 stocks that represent companies poised for growth and are fundamentally strong. More

Moderna released encouraging results for its late-stage trial of its flu vaccine. Now, MRNA stock is looking like more than a one-trick pony. More

Shares of AMC stock are surging today, as investors pile into the theater chain ahead of what could be a big movie release. More

Oil prices largely moderated in the first half of 2023, but as they slowly climb upward, investors should avoid these oil stocks. More

Amidst economic turbulence, explore these consumer stocks to buy on the dip, offering tremendous long-term upside ahead. More

Subscriber Sign in